VEGFA and COVID-19: If these considerations prove to be true, the measurement of circulating VEGF-A could be an appropriate and noninvasive method to assess the occurrence of neurovascular dysfunction in long COVID-19 subjects or vaccinated individuals with cardiovascular or neurological symptoms not otherwise explained by instrumental tests.